Haoxi Health Technology Limited Class A ( (HAO) ) just unveiled an update.
Haoxi Health Technology Limited announced a change in its executive team with the resignation of Ms. Yu Guo as Chief Financial Officer on April 10, 2025, due to personal reasons. The company promptly appointed Ms. Dongxue Li as the new CFO, effective April 12, 2025, with a one-year term that may be extended. Ms. Li brings experience from her previous role as financial reporting manager at a subsidiary of the company and her tenure at Shanghai Youtuo Public Relations Consulting Co., Ltd.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
Haoxi Health Technology Limited’s stock is under pressure due to a combination of strong revenue growth and profitability improvements but is offset by weak cash flow performance and above-average valuation. The stock is further challenged by a bearish technical outlook, indicating potential downside risk. Investors should monitor improvements in cash flow and technical indicators for a clearer investment opportunity.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
YTD Price Performance: -65.84%
Average Trading Volume: 142,712
Technical Sentiment Signal: Strong Buy
See more data about HAO stock on TipRanks’ Stock Analysis page.